0001179110-13-013491.txt : 20130826 0001179110-13-013491.hdr.sgml : 20130826 20130826170704 ACCESSION NUMBER: 0001179110-13-013491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130822 FILED AS OF DATE: 20130826 DATE AS OF CHANGE: 20130826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actavis, Inc. CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: WATSON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUMMEL ALBERT F CENTRAL INDEX KEY: 0001236489 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 131060805 MAIL ADDRESS: STREET 1: PO BOX 3407 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 4 1 edgar.xml FORM 4 - X0306 4 2013-08-22 0 0000884629 Actavis, Inc. ACT 0001236489 HUMMEL ALBERT F 131 RIDGEFIELD ROAD NEWTOWN SQUARE PA 19073 1 0 0 0 Common Stock, par value $0.0033 2013-08-22 4 S 0 20000 134.4959 D 112776 D Common Stock, par value $0.0033 2013-08-23 4 S 0 4044 134.1616 D 108732 D Common Stock, par value $0.0033 2013-08-26 4 S 0 15956 134.4414 D 92776 D Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.00 to $134.84, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.00 to $134.68, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.01 to $135.30, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) in this Form 4. /s/ALBERT F. HUMMEL 2013-08-26